Pharma Counters India Competition Commission On ‘Market-Distorting’ Practices

A note by the Competition Commission of India has put the spotlight back on certain pharma industry practices that are seen as triggering non-competitive market outcomes. Pharma has called into question certain claims of the CCI, with some experts suggesting that the regulator may have also exceeded its remit.